Rahul Khanolkar

Rahul Khanolkar is an immunology researcher specializing in T‑cell biology and cancer immunotherapy. His work spans macrophage modulation, T‑cell engagers, and MAIT‑cell responses, with publications in leading peer‑reviewed journals. He is currently working at Accession Therapeutics as the Director of Pre-clinical Development and is involved in establishing the non-clinical packages for the various assets in Accession’s pipeline